Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Comprehensive Genotypic, Phenotypic, and Biochemical Characterization of Got2 Deficiency: A Progressive Neurodevelopmental Disorder With Epilepsy and Abnormal Movements Publisher Pubmed



German HM ; Zaki MS ; Usmani MA ; Karagoz I ; Efthymiou S ; Abdelhamid MS ; Arabiyat HA ; Ghaffar A ; Shahzad M ; Van Bokhoven H ; Ahmed ZM ; Yaghini O ; Hosseini N ; Majidinezhad M Show All Authors
Authors
  1. German HM
  2. Zaki MS
  3. Usmani MA
  4. Karagoz I
  5. Efthymiou S
  6. Abdelhamid MS
  7. Arabiyat HA
  8. Ghaffar A
  9. Shahzad M
  10. Van Bokhoven H
  11. Ahmed ZM
  12. Yaghini O
  13. Hosseini N
  14. Majidinezhad M
  15. Alavi S
  16. Bosma M
  17. Broeks MH
  18. Turkdogan D
  19. Suri M
  20. Laura De Godoy L
  21. Verhoevenduif NM
  22. Riazuddin S
  23. Gleeson JG
  24. Alves C
  25. Jans JJM
  26. Riazuddin S
  27. Houlden H
  28. Maroofian R

Source: Genetics in Medicine Published:2025


Abstract

Purpose Glutamic-oxaloacetic transaminase (GOT), also known as aspartate aminotransferase, catalyzes the reversible transamination of oxaloacetate and glutamate to aspartate and α-ketoglutarate. Two isoforms, cytosolic (GOT1) and mitochondrial (GOT2), are integral to the malate-aspartate shuttle, a key regulator of intracellular redox homeostasis. Recently, 5 patients with biallelic variants in GOT2 were described, presenting with developmental and epileptic encephalopathy. Methods We report 11 additional patients with homozygous GOT2 variants, along with additional data from 4 previously reported patients. Through genetic, clinical, and biochemical analyses, we further characterize the phenotypic spectrum of GOT2 deficiency. Results Most patients exhibited progressive neurodevelopmental delay, severe to profound intellectual disability, infantile epilepsy, progressive microcephaly, and hypotonia evolving into spasticity with axial hypotonia. Dysmorphic features included narrow foreheads, broad nasal tips, and tall or pointed chins. Neuroimaging revealed 2 severity groups based on cerebral volume loss and myelination defects. Thinning of the corpus callosum and white matter abnormalities were common. Biochemical profiling identified low aspartate and high glycerol-3-phosphate in dried blood spots as potential screening markers. Patient fibroblast cells showed reduced serine and glycine biosynthesis, rescuable by pyruvate supplementation. Conclusion These findings expand the phenotypic spectrum of GOT2 deficiency, establish it as a cause of developmental epileptic encephalopathy, and propose novel biomarkers for diagnosis and treatment. © 2025 The Authors.